METiS Therapeutics Company
METiS Therapeutics is a biotechnology company that aims to drive therapies in a wide range of disease areas by integrating drug discovery and delivery with AI, machine learning, and quantum simulation.
Funding Status:
Early Stage Venture
Industry:
Early Drug Development
Headquarters:
Cambridge, Massachusetts, United States
Total Funding:
86000000
Last Funding Date:
2021-12-07
Last Funding Type:
Series A
Employee Number:
11-50
Investors Number:
7
Founded Date:
2017-01-01